First, we checked the expression of both GLP1R and GIPR in a public dataset (GEO accessions GSE135251) consisting of bulk RNA sequencing results from samples of patients with MASH at various fibrosis stages and healthy liver controls. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatohepatitis.